Cargando…

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children

Detalles Bibliográficos
Autores principales:	Roarty, Cathal, Tonry, Claire, McFetridge, Lisa, Mitchell, Hannah, Watson, Chris, Waterfield, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833611/ https://www.ncbi.nlm.nih.gov/pubmed/33220726 http://dx.doi.org/10.1016/S1473-3099(20)30884-7

Ejemplares similares

Seroprevalence of SARS-CoV-2 antibodies in children of United Kingdom healthcare workers: a prospective multicentre cohort study protocol
por: Corr, Michael, et al.
Publicado: (2020)

Systematic review and meta-analysis assessing the diagnostic test accuracy of procalcitonin in the diagnosis of invasive bacterial infections in febrile infants: a study protocol
por: Norman-Bruce, Hannah, et al.
Publicado: (2022)

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
por: Del Zompo, Fabio, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in Spain
por: George, Thukalan Paulose
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain
por: Hoffmann, Christian, et al.
Publicado: (2020)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021)

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
por: Razafimahatratra, Solohery Lalaina, et al.
Publicado: (2021)

Seroprevalence and presentation of SARS-CoV-2 in pregnancy
por: Crovetto, Francesca, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees
por: Hanage, William P, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination
por: Frey, Sarah, et al.
Publicado: (2021)

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
por: Arora, Rahul K, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India
por: Malani, Anup, et al.
Publicado: (2021)

A two-stage approach to the joint analysis of longitudinal and survival data utilising the Coxian phase-type distribution
por: Donnelly, Conor, et al.
Publicado: (2017)

Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays
por: Kahre, Elisabeth, et al.
Publicado: (2021)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Open Surgery for Abdominal Aortic Aneurysm: 980 Consecutive Patient Outcomes from a High-Volume Centre in the United Kingdom
por: Blair, Robert, et al.
Publicado: (2023)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Diagnostic test accuracy of dipstick urinalysis for diagnosing urinary tract infection in febrile infants attending the emergency department
por: Waterfield, Thomas, et al.
Publicado: (2022)

Applying clinical decision aids for the assessment and management of febrile infants presenting to emergency care in the UK and Ireland: Febrile Infant Diagnostic Assessment and Outcome (FIDO) Study protocol
por: Umana, Etimbuk, et al.
Publicado: (2023)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut
por: Papasavas, P., et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020
por: Wang, Shichun, et al.
Publicado: (2022)

The presence of SARS-CoV2 antibodies in MS patients
por: Wallach, Asya I., et al.
Publicado: (2021)

Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2
por: McConnell, David, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 in people living with HIV
por: Yamamoto, Shinya, et al.
Publicado: (2021)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

Letter to the editor: Six‐month antibody kinetics and durability in liver transplant recipients after two doses of SARS‐CoV‐2 mRNA vaccination
por: Chang, Amy, et al.
Publicado: (2022)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies in South Korea
por: Lee, Kwangmin, et al.
Publicado: (2021)

SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
por: Anichini, Gabriele, et al.
Publicado: (2021)

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021)

Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
por: Bobrovitz, Niklas, et al.
Publicado: (2021)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia
por: Conte, William L
Publicado: (2020)

Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019
por: Huang, Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d7ecbj46vvoajpj3lchvcheiku